Precision Medicine News and Updates | Precision Medicine Online
WEBResearchers are planning a clinical trial after four metastatic FGFR2 fusion-positive pancreatic cancer patients responded to FGFR-directed therapy. Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.
Precision Oncology News - Precision Medicine Online
WEBSep 16, 2024 · Indiana University, Indiana Biosciences Research Institute Form Precision Medicine Center. Sep 19, 2024. New Multi-Cancer Detection Data Speak to Both Promises and Cautions of Blood-Based Assays. Sep 18, 2024. Amgen's Lumakras Combo Scores High Response Rate in First-Line KRAS-Mutant Colorectal Cancer. Sep 18, 2024.
Breaking News - Precision Medicine Online
WEBSep 25, 2024 · NIH Awards $27M for Genomics-Enabled Learning Health System Network. The agency has committed $5.4 million for the first year of the five-year program to establish a network to analyze and improve how genomic information is integrated into patient care. Sep 23, 2024.
Precision Medicine Diagnostics
WEBKSQ Therapeutics Gets FDA Clearance to Begin Phase I/II Trial of TIL Therapy KSQ-004EX. The firm will evaluate the engineered cell therapy in patients with melanoma, and non-small cell lung, head and neck, colorectal, pancreatic, and …
Disease Research & Diagnostics News | Precision Medicine Online
WEBNews and analysis on disease research and diagnostics from Precision Medicine Online.
Autoimmune Disease Research News - Precision Medicine Online
WEBJun 20, 2024 · JW Therapeutics, 2seventy Bio Partner to Develop Cell Therapy for Autoimmune Diseases in China. News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more from Precision Medicine Online.
artificial intelligence - Precision Medicine Online
WEBJul 24, 2024 · News and reporting on artificial intelligence from Precision Medicine Online Precision Oncology
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing …
WEBJan 4, 2023 · NEW YORK – Looking back at 2022, plenty of new CAR T-cell, radioligand, and biomarker-defined treatments entered the market, as did new tissue and liquid biopsy tests to identify cancer patients eligible for these therapies.
Pfizer's Beqvez Bests Standard Hemophilia B Care in Trial, But …
WEB21 hours ago · NEW YORK – Results from Pfizer’s BENEGENE-2 Phase III trial affirm the company’s new gene therapy for hemophilia B leads to fewer bleeds for most patients, though researchers are unsure why some stop responding to the one-time treatment. "The findings of this Phase III study showed that ...
VieCure Raises $45M to Scale its Precision Oncology Decision …
WEB23 hours ago · NEW YORK – VieCure said on Monday that it has raised $45 million, which it will put toward advancing its next-generation clinical decision support solution and expanding the scale of its commercial operations. The financing round, which was led by Northpond Ventures, will support the Denver ...